FOCUS and SCOPE
The International Journal of Advances in Medical Biotechnology is an interdisciplinary journal publishing research within the field of Medical Sciences and Biotechology, and correlated applications. It publishes technical and scientific papers on fundamental aspects and technologies in such areas as biopolymers, biomaterials, medical chemistry, drug delivery, health, nanotechnology, pharmaceuticals, metals in medicine, tissue engineering and regenerative medicine.
Hypotheses - Nearly all scientific papers benefit from inclusion of a statement of hypothesis. Such statements should be concise, declarative, and describe the one or more key hypotheses upon which the manuscript is based. Inclusion of a hypothesis statement makes it simple to contrast the hypothesis with the most relevant previous literature and point out what the authors feel is distinct about the current hypothesis (novelty). It also permits the authors to describe why they feel it would be important to prove the hypothesis correct or refute it (significance).
Researchers in university and industry; users and manufacturers within the areas of medical chemistry, medical supplies and medical equipment.
International Journal of Advances in Medical Biotechnology is an international peer-reviewed research journal that publishes Research Papers, Short Communications, Reviews, Mini-reviews. It publishes scientific discoveries and inventions in the areas of medical biotechnology and chemical medicine technology, including their translation into commercial products and processes. Submitted papers should include new developments and significant advances to the field and understanding of the topic. Please read what the Journal’s Aims and Scope include for a detailed view of the publication areas.
Types of matter
We consider to analyze content articles as commissioned, but the Journal also warmly welcomes new ideas. Please contact the Editorial Office (email@example.com) with your proposal; once a proposal is accepted or commissioned, detailed format guidelines will be provided. In general, the Journal prefers lively pieces of interest to a wider audience. All articles are subject to peer review.
Research Articles These constitute the major type of publication; details of the exact format for submission are given below. Important features required in a Research Paper include a short and concise Abstract; an Introduction that sets out the work in the context of the published literature and that clearly indicates the advances to the field; Experimental Procedures in sufficient detail that should allow replication of the work and include analysis of replication and precision of data; a concise presentation of Experimental Results, followed by a Discussion of significance of the findings that does not repeat earlier material; lastly, a concluding section should summarize the main findings and emphasize their implications to the more general field.
Short communication A Spotlight is a brief report on a hot topic, significant advance or discovery in the field, and should be written in a lively, accessible style. It should be lightly referenced, contain a one-sentence abstract, a provocative image and caption. It generally should not exceed 6 double-spaced manuscript pages (2500 words including 01 table and 3 figures).
A short article with relatively few references on an outstanding area, newsworthy development or other event. These articles should be written in a vibrant and accessible style, contain a one-sentence abstract and include a striking, captioned image.
Mini-review A Mini-review is a focused summary that contains relevant literature concerning any topic covered within the Aims and Scope of the Journal. These reviews should deal with cutting-edge advancements in the area. Mini-reviews should include an abstract, are generally no longer than 12 double-spaced manuscript pages (2500 words including few tables and figures) and be selectively referenced.
A focused, selectively referenced summary that assesses the relevant literature. Particularly effective when discussing cutting-edge advancements in the area.
Review A full-length critical Review should provide a summary and critical discussion of the relevant literature about any topic covered within the Aims and Scope of the Journal. Reviews should include an abstract and should contain 6000 words maximum, excluding references and tables.
SUBMISSION OF PAPERS
Papers may not be offered for publication elsewhere whilst under consideration by the International Journal of Advances in Medical Biotechnology. The corresponding author must obtain the consent of all co-authors for the submission of the paper. Papers accepted by the Journal for publication may not be published elsewhere without the permission of the JOURNAL and acknowledgement of the original source of the publication. IJAMB operates an online submission system. Details of how to submit and full author instructions can be found at:
Inadequately or incorrectly prepared manuscripts may expect delays or even rejection. Authors must therefore conform closely to the instructions given below. Authors for whom English is a second or foreign language may choose to have their manuscript professionally edited before submission to improve the manuscript text. A list of independent suppliers of editing services can be found at:
All services are paid for and arranged by the author, and use of one of these services does not guarantee acceptance or preference for publication.
This accepted version will be made publicly available 12 months after publication.
International Journal of Advances in Medical Biotechnology has published best practice guidelines on publication ethics in English. These describe our position on the major ethical principles of academic publishing and provide guidance on potential issues related to conflict of interest, plagiarism and editorial standards and processes. IJAMB encourages all prospective authors to read the guidelines to ensure that manuscripts submitted to the Journal adhere to our ethical standards.
Authors who submit a manuscript containing in vivo animal work should submit all relevant Ethics Committee approval and authorization details (e.g. institute and/or government) and all relevant reference numbers. Those details will be printed as a footnote to the paper.
STYLE AND LAYOUT OF PAPERS
Authors are advised to consult a recent issue of the Journal for guidance on style and layout. Although no absolute limit on length is prescribed, articles and review articles must be submitted in word format, taking into account the following considerations.
All papers must be written in clear, concise English. In general, research papers should be in the impersonal form. Non-English speaking authors who do not have a good command of written scientific English are advised to seek assistance, before submission.
Papers submitted to the Journal should conform as much as possible to the pattern set out below.
The title should be concise and explain the nature of the paper. If the paper was presented, wholly or in part, at a scientific meeting, this should be stated in a footnote. Write with only the first letter of the title in uppercase, with centralized alignment, Times New Roman font size 12, 1.0 spacing.
An abbreviated title of up to 80 characters should also be provided.
Please include each author’s surname and one in full, in addition to the authors’ affiliation. The name, address, email address and phone numbers of the corresponding author should be indicated clearly with*.
For original research articles, we require an abstract with a maximum of 200 words.
Authors should remember that the abstract is often the only portion of a paper read (as in abstracting journals) and the use of unusual acronyms or abbreviations should be avoided.
Appropriate key words (4-6) should be provided for indexing and abstracting. Authors should give careful consideration to the choice of key words to ensure the paper appears during searches for the appropriate topic.
This section should state the problem investigated, the aim of the work and previous relevant work with the appropriate references. Also, it must also indicate clearly the advances brought to the field.
The methods and materials utilized should be stated clearly in enough detail to permit the work to be repeated by others, if desired. Only new techniques have to be described in detail; known methods must have the adequate references.
These should be presented concisely, with tables or illustrations for clarity.
Adequate indication of the reproducibility of the results, level of experimental error and the statistical significance of the results should be presented. Lack of such information could lead to rejection of the paper.
The number of illustrations, graphs and chemical formulae utilized must be kept to a minimum, and only in exceptional cases will tables and graphs that derive from the same data be accepted for publication. Supporting information will be published online (subject to peer review).
Headings Authors should distinguish clearly between main and subsidiary headings. Headings should not be numbered.
Discussion This section should discuss the significance of the findings without repetition of the material in the Introduction and Results sections. The Results and Discussion sections may be combined when this simplifies the presentation.
Acknowledgements These should be kept to a minimum.
References It is most important that these be checked carefully and formatted in the Vancouver style. Authors should pay particular attention to the instructions given below.
FORMAT FOR SUBMISSION
( a ) All manuscripts must be submitted in A4 format, single column, using double spacing and leaving adequate margins. Each page should be numbered individually. Text lines should be numbered, with the numbers restarting on each page.
( b ) Tabular material must be clearly set out with the number of columns in each table kept to a minimum. Tables, numbered in a consecutive fashion with arabic numerals, must be typed on separate sheets and placed after the references, leaving sufficient space around the copy for printer's instructions. Tables must have concise headings that enable them to be comprehensible without reference to the main text. Please ensure that the data in columns are consistent in the number of significant figures.
( c ) Number illustrations with Arabic numerals in a consecutive fashion, in order of appearance in the text. Lettering on illustrations should be kept to a minimum and include essential details in the legend. Figures should be placed on separate sheets after the main body of the text.
Each figure must be saved as a separate file and include the source file (i.e. a file in the program in which the image was originally created). The figures should be of high resolution (300 dpi minimum for photos, 800 dpi minimum for graphs, drawings, etc., at the size the figure will be printed). Numbers and symbols that are incorporated in the figure must be large enough to be legible after reduction in figure size.
We cannot publish scans or photocopied figures or accept PowerPoint, Excel, Encapsulated PostScript (EPS), Roshal Archive (RAR) files. Suitable file types include Joint Photographic Experts Group (JPEG), Tagged Image File Format (TIFF) and Microsoft Word (doc or docx) files.
You must have appropriate written permission to reproduce previously published figures.
Please note: the Journal does accept colour figures and photographs as there is on-line publication.
( d ) Footnotes should be kept to a minimum and indicated by asterisks and daggers (*, †).
( e ) Number compounds with bold arabic numerals ( 1 , 2 ).
( f ) Symbols, formulae and equations must be written carefully. The symbols recommended in the various parts of the British Standard 1991 should be used. SI units should be used; these are described in, for example, the British Standards Publication PD 5686, The Use of SI Units.
For biochemical nomenclature, as far as possible authors should follow the recommendations of the IUPAC-IUB Commission of Biochemical Nomenclature.
Chemicals when first used should be given the systematic name along with the trivial name or abbreviation in brackets, following which the trivial name/abbreviation can be used.
For enzymes, authors are requested to quote the Enzyme Commission (EC) number and systematic name once in the abstract and once in the text, both times after the first mention of the enzyme.
Trade names, where used, should be indicated and acknowledged as such.
( g ) Plants, animals and microorganisms should be given their full binominal Latin name, in italic. They must appear in the title, abstract, headings and legends of tables and figures, and on the first mention in the text. A collection number, strain number or name should be quoted, e.g. Escherichia coli (K12). Thereafter, abbreviate them in the text, e.g. E. coli.
( h ) The names and location of suppliers/makers of equipment, chemicals, etc. should be given. The details should be given in the first mention, then subsequently only the maker’s/supplier’s name.
( i ) References should be formatted in the Vancouver style. Unpublished work should be referred to only in the text: (Smith J, unpublished) (Brown CD, private communication).
References to the literature should be indicated by numerical superscripts 1 in order of appearance 2,3 and following any punctuation. 4–6. The numbers appear in exponent or superscript, in the numerical sequence of the quotations.
References should be listed in numerical order at the end of the paper, indicating all the authors with their initials after the respective surnames. Give the full title of the paper in the language in which it first appeared or an accurate English translation. Journal titles should be abbreviated, as in Chemical Abstracts, Biological Abstracts or Medline. If the journal is not included in these lists, then give the title in full. Where possible, the Digital Object Identifier (DOI) for the reference should be included at the end of the reference.
Please use the following style and order: author's surname, initial(s) of forename(s), paper title, journal title (in italic), volume number (in bold), first and last page numbers, year of publication (in brackets) e.g.:
1.Patel TD and Bott TR, Oxygen diffusion through a developing biofilm of Pseudomonas fluorescens . J Chem Technol Biotechnol 52 :187–199 (1991).
2.Barros MRA, Oliveira AC and Cabral JMS, Integration of enzyme catalysis in an extractive fermentation process, in Biocatalysis in Organic Media , ed by Laane C, Tramper J and Lilly MD. Elsevier Science Publishers, Amsterdam, pp 185–196 (1987).
3.Bortun AI, Pardini JJ, Butler CJ, Khainokov SA and Garcia JR, Zirconium based inorganic ion exchangers, in Ion Exchange Technology for Today and Tomorrow, Proc. IEX2004 Cambridge, UK, ed. Cox M, Society of Chemical Industry, London, pp 125-132 (2004)
When patents are quoted, provide the name of the applicant(s), the title, the country and patent number (or application number) and the year of publication, thus:
4. Hegner MB and Wendt KL, Method of sorting seeds. UK Patent 1470133 (1977).
Online citations to online-only journals and books should indicate the author, title, website and date of access:
5. Wright NA, The Standing of UK Histopathology Research 1997–2002. http://pathsoc.org.uk [accessed 7 October 2004].
All other online citations should only appear in the text with the author’s name and the website address: (Brown CD (http://biotech.ac.uk)).
( j ) IJAMB accepts submission of supporting information, which may include extensive tables, graphs, spectra, calculations, and other material beyond what is essential to the printed paper. This will be included in the online edition of the Journal but will not be part of the printed article. Supporting information should be denoted as such when submitting via ScholarOne Manuscripts. It should be uploaded as a separate file when the manuscript is submitted for peer review.
The International Journal of Advances in Medical Biotechnology provides authors with Accepted Articles service, whereby peer reviewed, accepted articles, are published online within days of acceptance, without having been copyedited or typeset. The articles are available as a PDF and can be cited using their Digital Object Identifier (DOI) numbers. For more information on DOIs, please see http://www.doi.org.faq.html. Since Accepted Articles are not considered to be final, changes may be made after the Accepted Article online publication date. Once copyedited and typeset, the article will be removed from the Accepted Articles area and will appear instead in Early View.
The implementation of the Accepted Articles service has been designed to ensure the earliest possible circulation of research papers immediately after acceptance, considerably reducing time to publication.
The proofs will be emailed as PDF files to the corresponding author. Proofs must be corrected and returned to the publishers within 48 hours of receipt; failure to do this will result in delay in publication. Author's corrections must be restricted to the printer's and/or factual errors.
There are no page charges. Free access to the final PDF of the article will be available via Author Services.
The author (s) authorizes the publication of the article in the journal;
Authors grant IJAMB the copyright, with the work simultaneously licensed under the Creative Commons Attribution License, which allows the sharing of the work with acknowledgment of authorship and initial publication in this journal.
FEES FOR SUBMISSION AND PUBLICATION OF TEXTS
The International Journal of Advances in Medical Biotechnology (IJAMB) does not charge any fees for published texts, nor for those submitted for evaluation, review, publication, distribution or download.
All IJAMB articles are published with DOI (Digital Object Identifier).
O (s) autor (es) autorizam a publicação do artigo na revista;
Os autores concedem ao IJAMB os direitos autorais, com a obra simultânea licenciada sob uma Creative Commons Attribution License, que permite o compartilhamento da obra com o reconhecimento de autoria e publicação inicial nesta revista.